Cholesterol produced by astrocytes in the brain is required for the production of amyloid-beta. The findings shed light on how and why amyloid-beta forms, and may explain why genes associated with cholesterol have been implicated as risk factors for Alzheimer's disease.
Teens who find themselves in intense, controlling relationships, where they are denied healthy external friendships and self-discovery, and psychologically controlling parents, have a higher risk for high blood pressure later in life.
Study identifies a critical role a protein called Cep55 plays in brain development and abscission, the final step in cell division.
People are reporting an uptick in personal "doomscrolling" activities online. Marked by consuming excessive amounts of negative content during one sitting, doomscrolling may be linked to anxiety. Researchers provide suggestions about how people can halt doomscrolling activities.
Study reveals there are differences in genes and the genetic burdens that underpin ASD between males and females. Researchers also found specific differences in the ways the brains of girls on the autism spectrum respond to different social cues.
Study explains the human tendency to look at a situation, or object, that needs improvement in different contexts, and instead, generally believe adding an element is a better solution than removing one.
A new sensor can monitor communication within the brain in ways never previously possible. The sensor has already deciphered why some Alzheimer's drugs have limited effectiveness and why patients often regress after stopping the medications.
Non-invasive focused ultrasound appears to be beneficial in the treatment of Parkinson's disease for patients whose symptoms are poorly controlled by traditional medications.
A baby's first breath triggers a signaling system in the brainstem that helps support early breathing. The findings shed light on how problems with this neuropeptide system can increase the risk of SIDS.
TEPP-46, a drug developed for the treatment of cancer and showed promise for the treatment of multiple sclerosis, could make MS symptoms worse, a new study reports. The drug appears to redirect inflammation away from the spinal cord and directly into the brain.